AMA Releases Opioid Toolboxes for Alabama and Rhode Island

Posted February 22, 2017

A Health Care Professional’s Toolbox to Reverse the Opioid Epidemic

Recent News

News Jul 7, 2017
Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population
We investigated prescribing patterns for five opioid use disorder (OUD) medications: 1) injectable naltrexone, 2) oral naltrexone, 3) sublingual or […]
News Jul 7, 2017
An Evidence-Based Recommendation to Increase the Dosing Frequency of Buprenorphine During Pregnancy
Dose-adjusted plasma concentrations of buprenorphine are significantly decreased during pregnancy compared to the non-pregnant state. This observation suggests that pregnant […]

This content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.

Funding for this initiative was made possible (in part) by grant nos. 5U79TI024697-03 and 1U79TI026556-01 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.